The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Nov. 05, 2019
Filed:
Apr. 14, 2016
Applicants:
Mackay Memorial Hospital, Taipei, TW;
Yeou-ping Tsao, Taipei, TW;
Tsung-chuan Ho, Taipei, TW;
Inventors:
Yeou-Ping Tsao, Taipei, TW;
Tsung-Chuan Ho, Taipei, TW;
Assignee:
MacKay Memorial Hospital, Taipei, TW;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/08 (2019.01); C07K 7/06 (2006.01); C07K 14/00 (2006.01); A61P 7/06 (2006.01); A61P 17/10 (2006.01); A61P 27/02 (2006.01); A61P 17/06 (2006.01); A61P 21/00 (2006.01); A61P 21/04 (2006.01); A61P 19/06 (2006.01); A61P 25/28 (2006.01); A61P 1/16 (2006.01); A61P 11/06 (2006.01); A61P 37/06 (2006.01); A61P 17/00 (2006.01); A61P 19/02 (2006.01); A61P 37/08 (2006.01); A61P 3/10 (2006.01); A61P 1/00 (2006.01); A61P 11/00 (2006.01); A61P 25/00 (2006.01); A61P 25/16 (2006.01); A61P 29/00 (2006.01); A61P 1/04 (2006.01); A61P 9/14 (2006.01); A61K 45/06 (2006.01); A61P 27/06 (2006.01); A61P 9/10 (2006.01); A61P 31/00 (2006.01); A61P 9/00 (2006.01); A61P 27/04 (2006.01); A61P 31/12 (2006.01); A61P 35/02 (2006.01); A61P 31/04 (2006.01); A61P 33/02 (2006.01); A61P 35/04 (2006.01); A61P 31/10 (2006.01); A61P 35/00 (2006.01); A61K 38/00 (2006.01);
U.S. Cl.
CPC ...
A61K 38/08 (2013.01); A61K 45/06 (2013.01); A61P 1/00 (2018.01); A61P 1/04 (2018.01); A61P 1/16 (2018.01); A61P 3/10 (2018.01); A61P 7/06 (2018.01); A61P 9/00 (2018.01); A61P 9/10 (2018.01); A61P 9/14 (2018.01); A61P 11/00 (2018.01); A61P 11/06 (2018.01); A61P 17/00 (2018.01); A61P 17/06 (2018.01); A61P 17/10 (2018.01); A61P 19/02 (2018.01); A61P 19/06 (2018.01); A61P 21/00 (2018.01); A61P 21/04 (2018.01); A61P 25/00 (2018.01); A61P 25/16 (2018.01); A61P 25/28 (2018.01); A61P 27/02 (2018.01); A61P 27/04 (2018.01); A61P 27/06 (2018.01); A61P 29/00 (2018.01); A61P 31/00 (2018.01); A61P 31/04 (2018.01); A61P 31/10 (2018.01); A61P 31/12 (2018.01); A61P 33/02 (2018.01); A61P 35/00 (2018.01); A61P 35/02 (2018.01); A61P 35/04 (2018.01); A61P 37/06 (2018.01); A61P 37/08 (2018.01); C07K 7/06 (2013.01); C07K 14/001 (2013.01); A61K 38/00 (2013.01);
Abstract
Disclosed herein are synthetic peptides and compositions comprising the same, for the treatment and/or prophylaxis of a disease, disorder and/or a condition related to inflammation. Also disclosed herein are methods of treating and/or preventing a disease, disorder and/or a condition related to inflammation, by administering to a subject in need of such treatment a composition containing a therapeutically effective amount of a synthetic peptide of the present disclosure.